GL1X · GenesisL1 explorer

Research workbench

Crystal structure of DHQ1 from salmonella typhi covalently modified by compound 7

Analyse Crystal structure of DHQ1 from salmonella typhi covalently modified by compound… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6SFE
Type
protein
Length
504 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3-dehydroquinate dehydratase
EC
4.2.1.10
UniProt
P24670
Ligands
L9Z
Pockets
6 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B3-dehydroquinate dehydratase (EC 4.2.1.10)protein25246% helix, 20% strandP24670

Ligands and binding sites

  • L9Z · (1~{S},3~{S},4~{S},5~{R})-3-(aminomethyl)-3,4,5-tris(hydroxyl)cyclohexane-1-carboxylic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1650.680.9523L9Z
2680.660.9424L9Z
3980.450.7920empty
4680.370.7819empty
5530.360.7914empty

Interfaces

1 interface between chains.

  • A–B · 1094 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 6SFE · Crystal structure of DHQ1 from salmonella typhi covalently modified by compound 7 · the same entry in another collection · chain A against A, TM-score 1.00
  • P24670 · AlphaFold monomer V2.0 prediction for 3-dehydroquinate dehydratase (P24670) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.